US 12,220,549 B2
Method, system, and apparatus for dermatological treatment
Jongju Na, Songpa-Gu (KR)
Assigned to Serendia, LLC, Lake Forest, CA (US)
Filed by Serendia, LLC, Lake Forest, CA (US)
Filed on May 31, 2024, as Appl. No. 18/680,754.
Application 18/680,754 is a continuation of application No. 17/131,711, filed on Dec. 22, 2020.
Application 17/131,711 is a continuation of application No. 15/724,261, filed on Oct. 3, 2017, granted, now 10,869,812, issued on Dec. 22, 2020.
Application 15/724,261 is a continuation of application No. 15/096,686, filed on Apr. 12, 2016, granted, now 9,775,774, issued on Oct. 3, 2017.
Application 15/096,686 is a continuation of application No. 13/825,083, granted, now 9,320,536, issued on Apr. 26, 2016, previously published as PCT/KR2012/001335, filed on Feb. 22, 2012.
Application 13/825,083 is a continuation of application No. 13/060,274, filed on Mar. 30, 2011, granted, now 8,979,912, issued on Mar. 17, 2015.
Claims priority of provisional application 61/449,080, filed on Mar. 3, 2011.
Prior Publication US 2024/0398663 A1, Dec. 5, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61H 39/08 (2006.01); A61B 1/06 (2006.01); A61H 15/02 (2006.01); A61H 39/00 (2006.01); A61M 37/00 (2006.01); A61N 1/05 (2006.01); A61N 1/30 (2006.01); A61N 1/32 (2006.01); A61N 1/36 (2006.01); A61N 5/06 (2006.01); A61B 17/34 (2006.01); A61H 15/00 (2006.01); A61H 23/02 (2006.01)
CPC A61M 37/00 (2013.01) [A61B 1/0655 (2022.02); A61H 15/02 (2013.01); A61H 39/002 (2013.01); A61H 39/007 (2013.01); A61H 39/086 (2013.01); A61N 1/0502 (2013.01); A61N 1/30 (2013.01); A61N 1/328 (2013.01); A61N 1/36017 (2013.01); A61N 5/0616 (2013.01); A61N 5/062 (2013.01); A61N 5/0624 (2013.01); A61B 2017/3409 (2013.01); A61H 2015/0014 (2013.01); A61H 23/02 (2013.01); A61H 2039/005 (2013.01); A61H 2201/0153 (2013.01); A61H 2201/105 (2013.01); A61H 2201/1207 (2013.01); A61H 2201/1604 (2013.01); A61H 2201/169 (2013.01); A61H 2201/5007 (2013.01); A61H 2201/5097 (2013.01); A61H 2205/022 (2013.01); A61H 2205/04 (2013.01); A61H 2205/06 (2013.01); A61H 2205/065 (2013.01); A61H 2205/084 (2013.01); A61H 2205/10 (2013.01); A61H 2205/12 (2013.01); A61M 2037/0007 (2013.01); A61M 37/0015 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/0046 (2013.01); A61M 2037/0061 (2013.01); A61M 2205/8206 (2013.01); A61N 2005/0644 (2013.01); A61N 2005/0652 (2013.01); A61N 2005/0659 (2013.01); A61N 2005/0661 (2013.01)] 18 Claims
OG exemplary drawing
 
1. An apparatus for treating dermatological tissue, comprising:
a user holdable device, an end of the user holdable device defining a surface configured to receive a needle module,
wherein the end of the user holdable device is capable of being releasably coupled to the needle module that includes a movable needle assembly that includes a plurality of needles, wherein the needle assembly is located past the end of the user holdable device when the needle module is releasably coupled to the user holdable device, and
wherein the user holdable device includes a motor capable of moving the needle assembly to deploy the plurality of needles to penetrate dermatological tissue to a desired depth, and wherein the desired depth is selectable by a user;
a signal generator, wherein the signal generator is capable of being coupled to the plurality of needles to provide a radio frequency signal, and wherein an intensity of a radio frequency signal is selectable by the user;
at least one processor,
wherein the at least one processor is configured to provide a signal to cause the motor to deploy the plurality of needles to the desired depth,
wherein the at least one processor is configured to provide a signal to cause the signal generator to provide the intensity of the radio frequency signal to the plurality of needles; and
at least one display.